Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OD-141309 is a topical antiseptic drug candidate being developed by Zaycor Healthcare, primarily for use as a preoperative skin disinfection preparation. The active ingredient is octenidine dihydrochloride, a bispyridinamine antiseptic with broad-spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria, fungi, and certain viruses. Octenidine works by binding to the negatively charged cell surfaces of microorganisms, leading to membrane disruption and cell death. Unlike some other antiseptics, it exhibits persistent antimicrobial activity and has a favorable safety profile with low systemic absorption. Zaycor is evaluating OD-141309 in clinical trials to support its approval in the United States, where octenidine is not yet widely available for preoperative use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on octenidine (Zaycor Healthcare).